Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intramolecular hydrophobic interactions are critical mediators of STAT5 dimerization
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-10-18
DOI
10.1038/srep35454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
- (2016) S Koschmieder et al. LEUKEMIA
- Nanomolar Inhibitors of the Transcription Factor STAT5b with High Selectivity over STAT5a
- (2015) Nagarajan Elumalai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- An SH2 domain model of STAT5 in complex with phospho-peptides define “STAT5 Binding Signatures”
- (2015) Eleonora Gianti et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
- (2015) Can Küçük et al. Nature Communications
- Inhibition of STAT5: A therapeutic option in BCR-ABL1-driven leukemia
- (2015) Angelika Berger et al. Oncotarget
- Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
- (2014) M. J. Kiel et al. BLOOD
- The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse
- (2014) O. R. Bandapalli et al. HAEMATOLOGICA
- Frequent STAT5B mutations in γδ hepatosplenic T-cell lymphomas
- (2014) A Nicolae et al. LEUKEMIA
- Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia
- (2014) M Kontro et al. LEUKEMIA
- Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein
- (2014) Abbarna A. Cumaraswamy et al. ACS Medicinal Chemistry Letters
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
- (2013) H. L. M. Rajala et al. BLOOD
- Structural and Dynamical Insights on HLA-DR2 Complexes That Confer Susceptibility to Multiple Sclerosis in Sardinia: A Molecular Dynamics Simulation Study
- (2013) Amit Kumar et al. PLoS One
- The role of STAT5 in lymphocyte development and transformation
- (2012) Lynn M Heltemes-Harris et al. CURRENT OPINION IN IMMUNOLOGY
- JAK/STAT signaling in hematological malignancies
- (2012) W Vainchenker et al. ONCOGENE
- Extent of Structural Asymmetry in Homodimeric Proteins: Prevalence and Relevance
- (2012) Lakshmipuram Seshadri Swapna et al. PLoS One
- The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
- (2011) M. Vogt et al. JOURNAL OF CELL SCIENCE
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery
- (2011) Roman A. Laskowski et al. Journal of Chemical Information and Modeling
- T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension
- (2011) P. Di Tommaso et al. NUCLEIC ACIDS RESEARCH
- Stat5 is indispensable for the maintenance ofbcr/abl-positive leukaemia
- (2010) Andrea Hoelbl et al. EMBO Molecular Medicine
- Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis
- (2009) Christian Baumgartner et al. AMERICAN JOURNAL OF PATHOLOGY
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
- (2008) N. Harir et al. BLOOD
- Interpretation of cytokine signaling through the transcription factors STAT5A and STAT5B
- (2008) L. Hennighausen et al. GENES & DEVELOPMENT
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started